Jennifer has been a leader in shaping Janssen’s global strategy of transformational medical innovation, successfully bringing to market critical new medicines that significantly improve the lives of patients. Under her leadership, Janssen is now among the world’s largest innovative pharmaceutical businesses.

Jennifer is a champion of diversity, equity and inclusion, which she sees as critical to insight, innovation and business success. Jennifer was named to Fortune magazine’s “Most Powerful Women” list the past five years. She serves and represents Johnson & Johnson on numerous industry boards.